Multimodality liquid biopsy for early monitoring and outcome prediction in first-line metastatic HER2-negative breast cancer: Final results of the prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG)- COMET study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreMultimodality liquid biopsy for early monitoring and outcome prediction in first-line metastatic HER2-negative breast cancer: Final results of the prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG)- COMET study.
Type de publicationJournal Article
Year of Publication2019
AuteursPierga J-Y, Silveira A, Tredan O, Tanguy M-L, Lorgis V, Dubot C, Jacot W, Goncalves A, Debled M, Levy C, Ferrero J-M, Jouannaud C, Mouret-Reynier M-A, Dalenc F, Lemonnier J, Berger F, Proudhon C, Bidard FClement
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.15_suppl.3019